Hawaii Launches Intervention Program to Prevent Youth Vaping

Aug.25.2022
Hawaii Launches Intervention Program to Prevent Youth Vaping
A study by Hawaii's Cancer Center aims to prevent e-cigarette use among rural youth through updated prevention measures.

Recent data from the Centers for Disease Control and Prevention (CDC) indicates that 18% of middle school students in Hawaii are using e-cigarettes, the highest rate among the 14 states surveyed. Of these young people, 30% are of Native Hawaiian or Pacific Islander ancestry, with e-cigarette use being highest among Hawaii's major ethnic groups.


Scott Okamoto, a researcher at the University of Hawaii Cancer Center, has been awarded $2.8 million in funding to develop interventions for preventing electronic cigarette use among rural youth in Hawaii. The project is funded by the National Institute on Drug Abuse and is based on Hoʻouna Pono, a substance abuse prevention program designed for rural Hawaii teenagers.


An electronic cigarette intervention program will update the existing Hoʻouna Pono curriculum and introduce new electronic cigarette and vaping prevention content, including social and print media campaigns in intermediate and multi-level public and public charter schools on the island of Hawaii. Over 500 students are expected to participate in this study within the next five years.


According to Okamoto, "To our knowledge, this is the first study that develops and tests e-cigarette prevention interventions specifically for rural youth in Hawaii. Our proposed intervention will educate young people about the risks of using e-cigarettes, while reflecting the cultural and relational values of Hawaii's rural youth and communities.


Teenagers and young adults who use e-cigarettes experience adverse respiratory symptoms including symptoms of asthma and bronchitis. E-cigarette use also increases the risk of using combustible tobacco, which is directly linked to lung cancer.


Preventing the use of electronic cigarettes through a reliable intervention program not only helps reduce serious respiratory illnesses but also prevents rural Hawaiian youth from potentially using combustible cigarettes.


Statement


This article is compiled from third-party information and is intended for industry exchange and learning purposes only.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the authenticity and accuracy of the content. The translation of this article is for the purpose of industry discussions and research only.


Due to limitations in the level of translation, the translated article may not fully express the original meaning. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on all domestic, Hong Kong, Macau, Taiwan, and foreign-related statements and positions.


The copyright of the compiled information belongs to the original media and author, and if there is any infringement, please contact for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Alan Zhao: What Altria’s on! PLUS Authorization Really Signals About FDA PMTA Enforcement
Alan Zhao: What Altria’s on! PLUS Authorization Really Signals About FDA PMTA Enforcement
In this in-depth commentary for 2Firsts, Alan Zhao examines what Altria’s on! PLUS authorization really signals about FDA PMTA enforcement. Beyond the headline approval, FDA’s language, process design and product choices offer rare insight into how nicotine pouch regulation is taking shape—and what it means for industry compliance, in one of the earliest expert reads of the decision.
Regulations
Dec.20 by 2Firsts Perspectives
Product | 5ml/2ml Dual Versions, Up to 45W Output: VAPORESSO Launches LUXE X3 on Official Website
Product | 5ml/2ml Dual Versions, Up to 45W Output: VAPORESSO Launches LUXE X3 on Official Website
VAPORESSO has listed the LUXE X3, a new addition to its LUXE X series, on its official website. The device features a 2,600mAh built-in battery, adjustable 5–45W output and a 0.8-inch digital display, and comes with a 5ml pod (2ml for the TPD version). The LUXE X3 has also appeared on some UK and US online retailers for pre-order, with prices below the company’s stated MSRP of $37.9.
Jan.19 by 2FIRSTS.ai
CBSA discloses seizure of 212,000 nicotine pouches at Pigeon River port of entry
CBSA discloses seizure of 212,000 nicotine pouches at Pigeon River port of entry
The Canada Border Services Agency said officers inspecting an incoming vehicle at the Pigeon River port of entry in June found 212,000 nicotine pouches and seized more than 29,000 Canadian dollars (about 21,170 U.S. dollars) in currency and cheques. A CBSA spokesperson disclosed the seizure this week in a Newswatch interview about enforcement operations over the past year.
Dec.30 by 2FIRSTS.ai
South Korea to Classify Synthetic Nicotine E-Cigarettes as Tobacco from April 2026
South Korea to Classify Synthetic Nicotine E-Cigarettes as Tobacco from April 2026
South Korea will implement amendments to its Tobacco Business Act on April 24, 2026, officially classifying synthetic nicotine liquid e-cigarettes as tobacco. This marks the first revision of the legal definition of tobacco since 1988. Once in effect, synthetic nicotine e-cigarettes will be subject to existing tobacco regulations, including health warnings, advertising restrictions, smoke-free area enforcement, and youth protection measures.
Dec.29 by 2FIRSTS.ai
Philip Morris International: Over $20 Billion Invested in the U.S. Since 2022; IQOS ILUMA to Launch Pending FDA Authorization
Philip Morris International: Over $20 Billion Invested in the U.S. Since 2022; IQOS ILUMA to Launch Pending FDA Authorization
Philip Morris International (PMI) said its U.S.-related investments have topped $20 billion since 2022, when it entered the U.S. market through its roughly $19 billion acquisition of Swedish Match. The company also said it plans to launch its heated tobacco product IQOS ILUMA in the United States pending authorization from the U.S. Food and Drug Administration (FDA).
Jan.16 by 2FIRSTS.ai
Product | ELFBAR launches new “4-in-1” e-cigarette kit: 4× (1ml + 5ml) design, 4 flavors per set
Product | ELFBAR launches new “4-in-1” e-cigarette kit: 4× (1ml + 5ml) design, 4 flavors per set
ELFBAR has launched the “4 in 1 Ultra 50 VAPE KIT” through multiple online sales channels in the UK. The kit combines four 1ml prefilled pods with four 5ml refill containers. The company claims it can deliver up to around 50,000 puffs, with a retail price of approximately £13.99.
Dec.31 by 2FIRSTS.ai